Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients

Breast cancer; Breast-related recurrences; Clinically-positive axillary nodes; Neoadjuvant chemotherapy; Sentinel lymph node; Survival; Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease-Free Survival; False Negative Reactions; Female; Humans; Incidence; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Micrometastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Survival Rate; Neoadjuvant Therapy